
Striving for Consensus on the Management of ALK-Positive Lung Cancer
Lung Cancer Update
00:00
The Evolution of Alk Rearrangements
Ross: I think as you rightly point out, it really is a very rapid evolution and Alk rearrangements were only identified in 2007. But we've had the development of first generation, second generation and now even later generation compounds. And really what we've seen is very meaningful impacts on patients in terms of outcomes and even survival with with these newer inhibitors. So I actually think the beginning of personalized therapy, really, the world shattered without. Absolutely.
Transcript
Play full episode